A Single Protein Material That Sticks, Heals, Grows Cells, and Stops Bleeding — All at Once | Research

The takeaway

A hybrid amyloid-resilin protein using Ure2 amyloidogenic peptide self-assembles into hydrogels with unprecedented multifunctionality: wet adhesion, self-healing, cell growth promotion, and hemostasis — outperforming commercial counterparts.

Outperformed commercial counterparts
A single pure protein biomaterial matched or exceeded the performance of existing commercial products across tissue engineering, cosmetic, and hemostasis applications

What the researchers found

Ure2 amyloidogenic peptide-resilin hybrid proteins self-assemble into supramolecular hydrogels with simultaneous wet adhesion, self-healing, rapid gelation, cell growth promotion, and hemostasis, outperforming commercial counterparts in tissue engineering and wound healing applications.

Why it matters

Most biomaterials excel at one property but sacrifice others. This single-protein material breaks that trade-off by combining structural order (amyloid) with disorder (resilin), creating a material that could simplify wound care, tissue engineering, and surgical applications — with one material replacing multiple commercial products.

The numbers in context

The strategy worked with multiple diverse proteins, each retaining function within the hydrogel network.

How the study worked

Biosynthetic hybrid proteins combining Ure2 amyloidogenic peptide sequences with resilin elastomeric polypeptide were expressed, purified, and characterized for self-assembly behavior, mechanical properties, adhesion, self-healing, and biological activity. Performance was tested in vitro (cell adhesion, proliferation, differentiation) and in vivo (tissue engineering, cosmetic, hemostasis applications).

Who was studied

Multiple protein constructs tested for self-assembly

What this study cannot tell us

Long-term biocompatibility and degradation in vivo need further study. Manufacturing scale-up of biosynthetic proteins may be challenging and costly. The comparison to commercial products may not reflect all clinical scenarios. Regulatory approval pathway for a novel protein biomaterial would be lengthy.

How to read the evidence

Preliminary-to-moderate evidence with both in vitro and in vivo validation. The material shows impressive performance across multiple applications, but clinical translation and long-term safety data are lacking.

When this study was published

Published in 2024, representing a novel approach to biomaterials design using ordered-disordered protein combinations.

The bigger picture

The combination of amyloid-forming peptides with elastic proteins represents a new design principle for biomaterials. Rather than viewing amyloid formation as purely pathological (as in Alzheimer's), this work harnesses amyloid's structural properties constructively. The approach is generalizable — any target protein can potentially be induced to form these multifunctional hydrogels using the Ure2 peptide sequence.

Questions still open

Can this material be manufactured cost-effectively at clinical scale?
What is the long-term immune response to implanted amyloid-resilin hydrogels?
Could different target proteins be incorporated to add drug delivery or sensing functionality?

Common questions

How can one material do so many different things?

The secret is in the molecular architecture. Amyloid-forming peptide regions create strong, ordered nanofiber structures that provide mechanical strength and adhesion. Resilin regions are disordered and elastic, providing flexibility and self-healing. Together, they create a material with properties that neither component could achieve alone — like a composite material, but made from a single protein. The nanoscale interplay between order and disorder is what produces the emergent multifunctionality.

Isn't amyloid the same thing that causes Alzheimer's disease?

Yes and no. Amyloid refers to a specific type of protein structure — tightly packed, cross-linked fibrils. In Alzheimer's, amyloid-β protein forms these structures in the brain where they're harmful. But the amyloid structure itself isn't inherently dangerous — it's incredibly strong and stable, which is exactly what makes it useful as a biomaterial. Many organisms use amyloid structures constructively (bacteria use them for biofilms, spiders use them in silk). This study harnesses amyloid's structural strength while keeping it safely outside the body in a biomaterial context.

Read the original research

A General and Convenient Peptide Self-Assembling Mechanism for Developing Supramolecular Versatile Nanomaterials Based on The Biosynthetic Hybrid Amyloid-Resilin Protein.

Advanced materials (Deerfield Beach, Fla.), 36(4), e2304364

View on PubMed ↗Publisher’s paper ↗

Citation

Wu, Junjun; Zhou, Lin; Peng, Hu; Wang, Zhaojun; Wang, Zhaoshi; Keasling, Jay D; Liu, Shike; Zhou, Guanghong; Ding, Shijie; Wang, Qiong; Wang, Xuejian; Chen, Xinxiu; Lang, Yifei; Xia, Mo; Guan, Xin; Dong, Mingsheng; Zhou, Jingwen; Chen, Jian. (2024). A General and Convenient Peptide Self-Assembling Mechanism for Developing Supramolecular Versatile Nanomaterials Based on The Biosynthetic Hybrid Amyloid-Resilin Protein.. Advanced materials (Deerfield Beach, Fla.), 36(4), e2304364. https://doi.org/10.1002/adma.202304364